Patents by Inventor Karin Van Den Hurk

Karin Van Den Hurk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for identifying subjects with aggressive melanoma skin cancer at diagnosis
    Patent number: 11078544
    Abstract: This disclosure is in the field of molecular biology and medical diagnosis and provides means and methods for determining the prognosis and disease outcome of a subject having a melanoma. More in particular, this disclosure provides a method for determining whether a subject having a melanoma has a poor prognosis, the method comprising the step of determining in a sample from the subject whether the LY75 promoter is methylated and if the LY75 promoter is methylated, classifying the subject as having a poor prognosis.
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: August 3, 2021
    Assignees: Universiteit Maastricht, Academisch Ziekenhuis Maastricht
    Inventors: Manon Van Engeland, Leander Pieter Jo Van Neste, Karin Van Den Hurk
  • METHOD FOR IDENTIFYING SUBJECTS WITH AGGRESSIVE MELANOMA SKIN CANCER AT DIAGNOSIS
    Publication number: 20190256926
    Abstract: This disclosure is in the field of molecular biology and medical diagnosis and provides means and methods for determining the prognosis and disease outcome of a subject having a melanoma. More in particular, this disclosure provides a method for determining whether a subject having a melanoma has a poor prognosis, the method comprising the step of determining in a sample from the subject whether the LY75 promoter is methylated and if the LY75 promoter is methylated, classifying the subject as having a poor prognosis.
    Type: Application
    Filed: March 1, 2019
    Publication date: August 22, 2019
    Inventors: Manon Van Engeland, Leander Pieter Jo Van Neste, Karin Van Den Hurk
  • Method for identifying subjects with aggressive melanoma skin cancer at diagnosis
    Patent number: 10260109
    Abstract: This disclosure is in the field of molecular biology and medical diagnosis and provides means and methods for determining the prognosis and disease outcome of a subject having a melanoma. More in particular, this disclosure provides a method for determining whether a subject having a melanoma has a poor prognosis, the method comprising the step of determining in a sample from the subject whether the LY75 promoter is methylated and if the LY75 promoter is methylated, classifying the subject as having a poor prognosis.
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: April 16, 2019
    Assignees: Universiteit Maastricht, Academisch Ziekenhuis Maastricht
    Inventors: Manon Van Engeland, Leander Pieter Jo Van Neste, Karin Van Den Hurk
  • METHOD FOR IDENTIFYING SUBJECTS WITH AGGRESSIVE MELANOMA SKIN CANCER AT DIAGNOSIS
    Publication number: 20180171410
    Abstract: This disclosure is in the field of molecular biology and medical diagnosis and provides means and methods for determining the prognosis and disease outcome of a subject having a melanoma. More in particular, this disclosure provides a method for determining whether a subject having a melanoma has a poor prognosis, the method comprising the step of determining in a sample from the subject whether the LY75 promoter is methylated and if the LY75 promoter is methylated, classifying the subject as having a poor prognosis.
    Type: Application
    Filed: May 26, 2016
    Publication date: June 21, 2018
    Inventors: Manon van Engeland, Leander Pieter Jo Van Neste, Karin Van Den Hurk